Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label Extension of Phase III Study CL-758010 with Alzhemed in Patients with Alzheimer's Disease
2006-006490-24Phase 3Completed
- Sponsor
- Neurochem Inc
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tramiprosate in Alzheimer's disease (AD), sponsored by Neurochem Inc. Primary endpoint: Long-term safety of Alzhemed. Started Feb 2007; status: completed.
02
Drugs
tramiprosate
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2006-006490-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006490-24.